Share

The Artificial Pancreas is Finally Coming to Market

According to a story in Tuesday’s USA Today, the first artificial pancreas systems are beginning to come to market. The artificial pancreas is a nickname given to wearable devices that take on the dual task of monitoring glucose levels as well as administering insulin. Also referred to as a “closed-loop” system because  the devices do...
Share

Endocrine Society Applauds CMS on CGM Coverage

The Endocrine Society praised the decision to extend access to therapeutic continuous glucose monitors (CGMs) to older Americans on intensive insulin therapy for diabetes. The Centers for Medicare & Medicaid Services (CMS) announced new coverage criteria for CGM devices Thursday. The guidance states that all Medicare individuals who have type 1 or type 2 diabetes...
Share

Five-Year Results of STAMPEDE Trial Show Bariatric Surgery’s Efficacy on Treating T2D

Researchers at Cleveland Clinic last month published the five-year results of STAMPEDE, a groundbreaking trial that compared intensive medical treatment and surgical treatment of uncontrolled type 2 diabetes (T2D). The results, published in the New England Journal of Medicine, showed that bariatric surgery plus intensive medical intervention was more effective in treating T2D than intensive...
Share

In Concert: Treating Diabetes & Heart Disease

in concert As the numbers of people with cardiovascular disease and diabetes are on the rise, so is the research on how to treat these comorbidities together. While no one treatment can apply to all patients, helping patients make proper lifestyle choices appears to be the key to longevity. Cardiovascular disease (CVD) is the leading cause of...
Share

City of Hope Sets New Goal for Type 1 Diabetes Cure

Curing type 1 diabetes in six years is the new goal of Duarte, Calif., based City of Hope’s Diabetes and Metabolism Research Institute. Through the generosity of the Wanek family and gifts from anonymous donors, the institution will be able to devote more than $50 million over the next six years to an innovative research...
Share

Endocrine Society Newsmakers in December

USA Today‘s Diagnosis: Diabetes Magazine—Dollars & Cents: Experts suggest ways to offset rising insulin costs Clinical Affairs Core Committee Chair Robert Lash, MD, discussed the importance of using diabetes medications as directed in the national newspaper’s digital magazine on diabetes. Le Monde —Perturbateurs endocriniens : la fabrique d’un mensonge (Endocrine disrupters: the manufacture of a...
Share

Endocrine Society Scientific Statement Available for Comment

A working draft of an Endocrine Society Scientific Statement has been posted online for members to view and submit comments. This Statement addresses the state of science on diabetic microvascular disease, and all Endocrine Society members with expertise in this area are invited to review the manuscript. Comments are due Thursday, December 22 at 5...

Diabetes Research Articles

Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.